These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 22498638)

  • 21. Predictors and burden of hospital readmission with recurrent Clostridioides difficile infection: a French nation-wide inception cohort study.
    Dinh A; Le Monnier A; Emery C; Alami S; Torreton É; Duburcq A; Barbier F
    Eur J Clin Microbiol Infect Dis; 2019 Jul; 38(7):1297-1305. PubMed ID: 30941532
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hospital cost of Clostridium difficile infection including the contribution of recurrences in French acute-care hospitals.
    Le Monnier A; Duburcq A; Zahar JR; Corvec S; Guillard T; Cattoir V; Woerther PL; Fihman V; Lalande V; Jacquier H; Mizrahi A; Farfour E; Morand P; Marcadé G; Coulomb S; Torreton E; Fagnani F; Barbut F;
    J Hosp Infect; 2015 Oct; 91(2):117-22. PubMed ID: 26253518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Burden of Clostridium difficile-associated disease among patients residing in nursing homes: a population-based cohort study.
    Yu H; Baser O; Wang L
    BMC Geriatr; 2016 Nov; 16(1):193. PubMed ID: 27884118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Attributable Healthcare Resource Utilization and Costs for Patients With Primary and Recurrent Clostridium difficile Infection in the United States.
    Zhang D; Prabhu VS; Marcella SW
    Clin Infect Dis; 2018 Apr; 66(9):1326-1332. PubMed ID: 29360950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hospital-acquired Clostridium difficile infection in Mainland China: A seven-year (2009-2016) retrospective study in a large university hospital.
    Xu Q; Chen Y; Gu S; Lv T; Zheng B; Shen P; Quan J; Fang Y; Li L
    Sci Rep; 2017 Aug; 7(1):9645. PubMed ID: 28852010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. How to: Surveillance of Clostridium difficile infections.
    Krutova M; Kinross P; Barbut F; Hajdu A; Wilcox MH; Kuijper EJ;
    Clin Microbiol Infect; 2018 May; 24(5):469-475. PubMed ID: 29274463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessing the risk and disease burden of Clostridium difficile infection among patients with hospital-acquired pneumonia at a University Hospital in Central China.
    Li C; Duan J; Liu S; Meng X; Fu C; Zeng C; Wu A
    Infection; 2017 Oct; 45(5):621-628. PubMed ID: 28497295
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trend, Risk Factors, and Costs of Clostridium difficile Infections in Vascular Surgery.
    Egorova NN; Siracuse JJ; McKinsey JF; Nowygrod R
    Ann Vasc Surg; 2015; 29(4):792-800. PubMed ID: 25595110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clostridium difficile infection in Ohio hospitals and nursing homes during 2006.
    Campbell RJ; Giljahn L; Machesky K; Cibulskas-White K; Lane LM; Porter K; Paulson JO; Smith FW; McDonald LC
    Infect Control Hosp Epidemiol; 2009 Jun; 30(6):526-33. PubMed ID: 19419272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence and Outcomes Associated With Clostridium difficile Infections: A Systematic Review and Meta-analysis.
    Marra AR; Perencevich EN; Nelson RE; Samore M; Khader K; Chiang HY; Chorazy ML; Herwaldt LA; Diekema DJ; Kuxhausen MF; Blevins A; Ward MA; McDanel JS; Nair R; Balkenende E; Schweizer ML
    JAMA Netw Open; 2020 Jan; 3(1):e1917597. PubMed ID: 31913488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. National point prevalence of Clostridium difficile in US health care facility inpatients, 2008.
    Jarvis WR; Schlosser J; Jarvis AA; Chinn RY
    Am J Infect Control; 2009 May; 37(4):263-70. PubMed ID: 19278754
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clostridium difficile infection in patients hospitalized with type 2 diabetes mellitus and its impact on morbidity, mortality, and the costs of inpatient care.
    Olanipekun TO; Salemi JL; Mejia de Grubb MC; Gonzalez SJ; Zoorob RJ
    Diabetes Res Clin Pract; 2016 Jun; 116():68-79. PubMed ID: 27321318
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hospital-acquired Clostridium difficile infection: an institutional costing analysis.
    Choi KB; Suh KN; Muldoon KA; Roth VR; Forster AJ
    J Hosp Infect; 2019 Jun; 102(2):141-147. PubMed ID: 30690051
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Economic impact of Clostridium difficile infection in a multihospital cohort of academic health centers.
    Pakyz A; Carroll NV; Harpe SE; Oinonen M; Polk RE
    Pharmacotherapy; 2011 Jun; 31(6):546-51. PubMed ID: 21923438
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Burden of Clostridioides difficile infection (CDI) - a systematic review of the epidemiology of primary and recurrent CDI.
    Finn E; Andersson FL; Madin-Warburton M
    BMC Infect Dis; 2021 May; 21(1):456. PubMed ID: 34016040
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost burden of Clostridioides difficile infection to the health service: A retrospective cohort study in Scotland.
    Robertson C; Pan J; Kavanagh K; Ford I; McCowan C; Bennie M; Marwick C; Leanord A
    J Hosp Infect; 2020 Nov; 106(3):554-561. PubMed ID: 32717202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Burden of Clostridium difficile infection between 2010 and 2013: Trends and outcomes from an academic center in Eastern Europe.
    Kurti Z; Lovasz BD; Mandel MD; Csima Z; Golovics PA; Csako BD; Mohas A; Gönczi L; Gecse KB; Kiss LS; Szathmari M; Lakatos PL
    World J Gastroenterol; 2015 Jun; 21(21):6728-35. PubMed ID: 26074711
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of Clostridium difficile infection on resource use and costs in hospitals in Spain and Italy: a matched cohort study.
    Asensio A; Di Bella S; Lo Vecchio A; Grau S; Hart WM; Isidoro B; Scotto R; Petrosillo N; Watt M; Nazir J
    Int J Infect Dis; 2015 Jul; 36():31-8. PubMed ID: 26003403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The prolongation of length of stay because of Clostridium difficile infection.
    Mitchell BG; Gardner A; Barnett AG; Hiller JE; Graves N
    Am J Infect Control; 2014 Feb; 42(2):164-7. PubMed ID: 24290226
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Excess length of stay and mortality due to Clostridium difficile infection: a multi-state modelling approach.
    van Kleef E; Green N; Goldenberg SD; Robotham JV; Cookson B; Jit M; Edmunds WJ; Deeny SR
    J Hosp Infect; 2014 Dec; 88(4):213-7. PubMed ID: 25441017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.